Jinhai Tian

Yinchuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

m6A methylation of circKPNA2 promotes colorectal carcinogenesis by activating the RIN1-Ras pathway.

m6A methylation of circKPNA2 promotes colorectal carcinogenesis by activating the RIN1-Ras pathway.

Journal: Epigenetics

Published: June 19, 2026

Correction: Immune microenvironment-dependent effects of age-associated Bifidobacterium strains on gut immunity and microbial diversity.

Correction: Immune microenvironment-dependent effects of age-associated Bifidobacterium strains on gut immunity and microbial diversity.

Journal: Frontiers in cellular and infection microbiology

Published: February 12, 2026

B cell subpopulations and their role in the pathogenesis of primary Sjögren's syndrome: insights from single-cell RNA sequencing.

B cell subpopulations and their role in the pathogenesis of primary Sjögren's syndrome: insights from single-cell RNA sequencing.

Journal: Frontiers in immunology

Published: July 13, 2025

Immune microenvironment-dependent effects of age-associated Bifidobacterium strains on gut immunity and microbial diversity.

Immune microenvironment-dependent effects of age-associated Bifidobacterium strains on gut immunity and microbial diversity.

Journal: Frontiers in cellular and infection microbiology

Published: June 01, 2025

LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression.

LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 expression.

Journal: Cancer medicine

Published: April 07, 2024

Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors.

Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors.

Journal: Cell & bioscience

Published: March 29, 2024

Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.

Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.

Journal: Molecular carcinogenesis

Published: January 16, 2024

RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor.

RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor.

Journal: Oncogene

Published: September 23, 2023

The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome.

The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome.

Journal: Clinical rheumatology

Published: August 03, 2023

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

Journal: Molecular carcinogenesis

Published: June 30, 2023

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: April 02, 2023

NKD1 targeting PCM1 regulates the therapeutic effects of homoharringtonine on colorectal cancer.

NKD1 targeting PCM1 regulates the therapeutic effects of homoharringtonine on colorectal cancer.

Journal: Molecular biology reports

Published: March 29, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026